Mpox, previously known as Monkeypox, has become a growing health concern in Nigeria. Caused by the Mpox virus, which belongs to the Orthopoxvirus genus (the same family as smallpox), this infectious disease presents symptoms such as a painful rash, swollen lymph nodes, fever, and muscle aches. While the illness is typically mild and most people recover within weeks, it can become severe, particularly in vulnerable groups like children, pregnant women, and those with weakened immune systems.
Transmission occurs through contact with infected animals, humans, or contaminated objects, as well as respiratory droplets. Despite efforts to control the outbreak, Mpox remains a significant challenge in Africa, with the World Health Organization recently declaring it a global public health emergency.
Nigeria has recorded 55 confirmed cases of Mpox across 21 states, though no deaths have been reported in 2024. The Nigerian Centre for Disease Control (NCDC) noted that the majority of cases are in males, who account for 70% of infections. To combat the spread, health officials are focusing on early detection, isolation, and personal protective measures in healthcare settings. A donation of 10,000 Jynneos vaccine doses from the U.S. offers hope for prevention, though challenges remain, including public misconceptions and insufficient healthcare resources.
